Moti Ramgopal

机构：Midway University, Indian River State College · ORCID：0000-0001-7448-1976

发表论文 145 篇 · 总被引 5398 次 · h-index 36

代表论文

• Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study (2025 · Nature Medicine · 被引 12)
• Once-Weekly Oral Islatravir Plus Lenacapavir Versus Daily Oral Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Persons With HIV-1 (2025 · Annals of Internal Medicine · 被引 9)
• Long-term metabolic changes with bictegravir/emtricitabine/tenofovir alafenamide or dolutegravir-containing regimens for HIV (2025 · AIDS Research and Therapy · 被引 6)
• Leronlimab Treatment for Multidrug-Resistant HIV-1 (OPTIMIZE): A Randomized, Double-Blind, Placebo-Controlled Trial (2025 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 6)
• 577. Week 48 Results of a Phase 2 Study Evaluating Once-weekly Oral Islatravir Plus Lenacapavir (2025 · Open Forum Infectious Diseases · 被引 6)
• Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV (2025 · AIDS · 被引 5)